During the last session, Aspira Women’s Health Inc (NASDAQ:AWH)’s traded shares were 2.27 million, with the beta value of the company hitting 1.97. At the end of the trading day, the stock’s price was $0.11, reflecting an intraday gain of 5.77% or $0.01. The 52-week high for the AWH share is $3.67, that puts it down -3236.36 from that peak though still a striking 27.27% gain since the share price plummeted to a 52-week low of $0.08. The company’s market capitalization is $1.94M, and the average intraday trading volume over the past 10 days was 4.78 million shares, and the average trade volume was 4.50 million shares over the past three months.
Aspira Women’s Health Inc (AWH) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 1.00. AWH has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.15.
Aspira Women’s Health Inc (NASDAQ:AWH) trade information
Aspira Women’s Health Inc (AWH) registered a 5.77% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.77% in intraday trading to $0.11, hitting a weekly high. The stock’s 5-day price performance is 10.00%, and it has moved by -51.33% in 30 days. Based on these gigs, the overall price performance for the year is -96.91%. The short interest in Aspira Women’s Health Inc (NASDAQ:AWH) is 0.97 million shares and it means that shorts have 0.08 day(s) to cover.
The consensus price target of analysts on Wall Street is $3.3, which implies an increase of 96.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3.3 and $3.3 respectively. As a result, AWH is trading at a discount of -2900.0% off the target high and -2900.0% off the low.
Aspira Women’s Health Inc (AWH) estimates and forecasts
In the rating firms’ projections, revenue will increase 161.38% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 5M as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 5M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 2.15M and 2.42M respectively. In this case, analysts expect current quarter sales to grow by 132.23% and then jump by 106.36% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 5.77%.
AWH Dividends
Aspira Women’s Health Inc is due to release its next quarterly earnings on 2024-Nov-18. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Aspira Women’s Health Inc (NASDAQ:AWH)’s Major holders
Aspira Women’s Health Inc insiders own 30.87% of total outstanding shares while institutional holders control 8.74%, with the float percentage being 12.64%.
